InvestorsHub Logo

tykundegex

06/23/19 4:09 PM

#274 RE: mybikeisorange #273

What intrigued me was how new the entity is. New website (and private registration), new Twitter account, not yet even listed on the list of companies at the techno Park in Spain, etc. And yet they claim to have been instrumental in promoting the success of C1.

Maybe a BDI spin-off that has been in sleath mode until now? Or perhaps simply a name change?

tykundegex

06/24/19 9:55 AM

#275 RE: mybikeisorange #273

I just received a reply to my inquiry about them:

---
53Biologics is a brand recently created by BDI biotechnology specifically to offer our services in the pharma sector.

Dyadic International did a strategic investment on BDI (16% of BDI belongs to Dyadic) two years ago to develop C1 (https://www.dyadic.com/dyadic-announces-important-multi-year-research-development-arrangement-advance-proprietary-c1-technology/). We have been working with C1 during more than 10 years when we, as part of Abengoa Bioenergy R&D team, developed strains and production processes for cellulolytic cocktails to be used in the 2G bioethanol.
---

I find it very encouraging that they'd spin-off a separate brand to focus on pharma with C1. Looking forward to a steady flow of progress on both the scientific and commercial fronts.